In addition, bile acids can bind to the nuclear Farnesoid X receptor (FXR), which is involved in hepatic lipid and glucose metabolism [81] and hence promotes metabolic liver dysfunction, leading to obesity, insulin resistance (see Figure 1), and nonalcoholic fatty liver disease (NAFLD). The gene discussed is NR1H4; the disease is obesity disorder.